Qt Imaging Holdings (QTI) Cash from Financing Activities (2021 - 2026)
Qt Imaging Holdings (QTI) posted quarterly Cash from Financing Activities of $159000.0 for Q1 2026, down 97.03% year-over-year from $5.4 million in Q1 2025, and down 98.66% quarter-over-quarter from $11.9 million in Q4 2025.
Qt Imaging Holdings (QTI) Cash from Financing Activities (2021 - 2026) Analysis & Trends
Qt Imaging Holdings (QTI) has reported Cash from Financing Activities for 6 consecutive years, with $159000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 97.03% year-over-year to $159000.0; the TTM figure through Mar 2026 stood at $13.2 million (up 160.65% YoY), while the FY2025 annual figure was $18.4 million, up 64.93% from the prior year.
- Cash from Financing Activities fell to $159000.0 in Q1 2026 per QTI's latest filing, from $11.9 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $11.9 million in Q4 2025 and bottomed at -$1.2 million in Q3 2024.
- Historically, Cash from Financing Activities has averaged $2.3 million across 5 years, with a median of $623485.0 in 2022.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities plunged 540.06% — and 2025, when it surged 1709.06%.
- Qt Imaging Holdings' Cash from Financing Activities stood at $675000.0 in 2022, then advanced by 18.91% to $802612.0 in 2023, then rose by 13.07% to $907525.0 in 2024, then soared by 1211.84% to $11.9 million in 2025, then slumped by 98.66% to $159000.0 in 2026.
- Business Quant data shows QTI's Cash from Financing Activities at $159000.0 in Q1 2026, $11.9 million in Q4 2025, and $571970.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Qt Imaging Holdings | 41.82 Mn | 30.90 Mn | 3.06 Mn | 9.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.04 Mn |
| Jun 30, 2026 | 9.04 Mn |
| Mar 31, 2026 | 159,000.00 |
| Mar 31, 2026 | 159,000.00 |
| Dec 31, 2025 | 11.91 Mn |
| Dec 31, 2025 | 11.91 Mn |
| Sep 30, 2025 | 571,970.00 |
| Sep 30, 2025 | 571,970.00 |
| Jun 30, 2025 | 523,716.00 |
| Jun 30, 2025 | 523,716.00 |
| Mar 31, 2025 | 5.35 Mn |
| Mar 31, 2025 | 5.35 Mn |
| Dec 31, 2024 | 907,525.00 |
| Dec 31, 2024 | 907,525.00 |
| Sep 30, 2024 | -1.18 Mn |
| Sep 30, 2024 | -1.18 Mn |
| Jun 30, 2024 | -32,548.00 |
| Jun 30, 2024 | -32,548.00 |
| Mar 31, 2024 | 11.43 Mn |
| Mar 31, 2024 | 11.43 Mn |